Evidence identified
Twenty-seven reviews were identified (published from 2016 to 2019) that examined the association between physical activity and health-related outcomes among people with impairments () (1–38). Each of the reviews focused on different subpopulations with impairments including four reviews that included people with multiple sclerosis, no reviews among people with a spinal cord injury, two reviews among children and adolescents with intellectual disabilities including Down syndrome, three reviews among older adults with Parkinson’s disease, 12 reviews included people with a history of stroke, two reviews including people with major clinical depression, 3 reviews among adults with schizophrenia, and one among children with attention deficit hyperactivity disorder ().
The primary outcomes for each review varied according to the population of interest. For instance, measures of physical function were most commonly reported for reviews of exercise interventions among adults with a history of stroke whereas measures of cognition were most commonly reported for the reviews among children with ADHD. None of the reviews included evidence published in 2019; most reviews included evidence published through 2017. The included bodies of evidence for each review was relatively small ranging from 3 to 39 included studies. Three reviews were reviews-of-reviews and synthesized the evidence from existing systematic reviews and meta-analyses. Extracted data for each review is included in Appendix A. A summary of the U.S. Physical Activity Guidelines evidence for people with common chronic conditions is provided within each Evidence Profile.
In general, these reviews had many limitations in their design, execution, and reporting. None of the systematic reviews were rated as having high credibility based on the AMSTAR 2 instrument. Ten were rated as having moderate credibility, 14 were rated as having low credibility, and the remaining 12 were rated as having critically low credibility. Given concerns regarding the comprehensiveness and the validity of the results presented in reviews rated as having critically low credibility, they were not incorporated into the final Evidence Profiles. presents the ratings for each review according to all the AMSTAR 2 main domains. Two additional reviews were excluded given the scope or focus of the reviews (7, 17). The paper by Christiansen 2019 (7) is not a systematic review and the review by Hendrey (2018) (17) was excluded given the research question (do resistance training interventions that have been studied among patients with a history of stroke adhere to American College of Sports Medicine guidelines?).
Table F1.1Systematic Reviews Assessed, by condition
View in own window
| Conditions | Outcomes | | | |
---|
Author, Year | MS | SCI | ID | Park | Stroke | MCD | Schizophrenia | ADHD | Risk of comorbid conditions | Physical function | Cognitive function | QOL | Last search date | # of included studies | AMSTAR 2 |
---|
People with multiple sclerosis |
---|
Alphonsus, 2019 (1) | ✕ | | | | | | | | | | | ✕ | NR 2017 | 18 | Low |
---|
Campbell, 2018 (5) | ✕ | | | | | | | | | ✕ | | | Sep 2017 | 7 | Low |
---|
Charron, 2018 (6) | ✕ | | | | | | | | | ✕ | | | Nov 2016 | 12 | Critically Low |
---|
Manca, 2018 (24) | ✕ | | | | | | | | | ✕ | | | May 2017 | 11 | Moderate |
---|
Morrison, 2017 (27) | ✕ | | | | | | | | | | ✕ | | May 2016 | 19 | Critically Low |
---|
Patterson, 2018 (28) | ✕ | ✕ | | | ✕ | | | | | ✕ | | | Aug 2017 | 9 | Moderate |
---|
Veneri, 2018 (34) | ✕ | | | | ✕ | | | | | ✕ | ✕ | ✕ | May 2016 | 32 | Critically Low |
---|
People with spinal cord injury |
---|
Eitivipart, 2019a (12) | | ✕ | | | | | | | | ✕ | | | Aug 2018 | 16 | Critically Low |
---|
Gaspar, 2019 (14) | | ✕ | | | | | | | | ✕ | | ✕ | Feb 2017 | 25 | Critically Low |
---|
Melo, 2019 (25) | | ✕ | | | | | | | | ✕ | | | Nov 2015 | 7 | Critically Low |
---|
Patterson, 2018 (28) | ✕ | ✕ | | | ✕ | | | | | ✕ | | | Aug 2017 | 9 | Critically Low |
---|
People with intellectual disabilities |
---|
Maïano, 2018 (23) | | | ✕ | | | | | | | ✕ | | | Mar 2018 | 15 | Low |
---|
Maïano, 2019 (22) | | | ✕ | | | | | | | ✕ | | | Jun 2017 | 11 | Moderate |
---|
People with Parkinson’s disease |
---|
Cugusi, 2017a (8) | | | | ✕ | | | | | | ✕ | | ✕ | Feb 2017 | 6 | Low |
---|
Ćwiękała-Lewis, 2017 (10) | | | | ✕ | | | | | | ✕ | | ✕ | Apr 2015 | 11 | Critically Low |
---|
Dos Santos Delabary, 2017 (11) | | | | ✕ | | | | | | ✕ | | ✕ | Aug 2017 | 5 | Low |
---|
Kalyani, 2019 (19) | | | | ✕ | | | | | | ✕ | ✕ | | Sep 2017 | 12 | Critically Low |
---|
Stuckenschneider, 2019 (32) | | | | ✕ | | | | | | | ✕ | | Mar 2018 | 11 | Moderate |
---|
People with a history of stroke |
---|
Bonini-Rocha, 2018 (3) | | | | | ✕ | | | | | ✕ | | | Mar 2017 | 11 | Moderate |
---|
Boyne, 2017 (4) | | | | | ✕ | | | | | ✕ | | | Nov 2015 | 20 | Low |
---|
Cugusi, 2017b (9) | | | | | ✕ | | | | | ✕ | | | Oct 2016 | 15 | Moderate |
---|
Ge, 2017 (15) | | | | | ✕ | | | | | ✕ | | | Feb 2017 | 32 | Moderate |
---|
Hendrey, 2018b (17) | | | | | ✕ | | | | | ✕ | | | Oct 2016 | 39 | N/A |
---|
Ilunga Tshiswaka, 2018 (18) | | | | | ✕ | | | | | ✕ | | | Oct 2016 | 29 | Critically Low |
---|
Li, 2018 (21) | | | | | ✕ | | | | | ✕ | | | NR | 5 | Low |
---|
Miranda, 2018 (26) | | | | | ✕ | | | | | ✕ | | | Nov 2017 | 12 | Low |
---|
Patterson, 2018 (28) | ✕ | ✕ | | | ✕ | | | | | ✕ | | | Aug 2017 | 9 | Moderate |
---|
Pogrebnoy, 2019 (29) | | | | | ✕ | | | | | ✕ | | | Aug 2018 | 10 | Low |
---|
Schröder, 2019 (30) | | | | | ✕ | | | | | ✕ | | | Apr 2018 | 7 | Low |
---|
Veneri, 2018 (34) | ✕ | | | | ✕ | | | | | ✕ | ✕ | ✕ | NR | 32 | Critically Low |
---|
Wiener, 2019 (35) | | | | | ✕ | | | | | ✕ | | | Jan 2018 | 6 | Low |
---|
Wu, 2018 (36) | | | | | ✕ | | | | | ✕ | | | May 2017 | 6 | Critically Low |
---|
Zou, 2018a (37) | | | | | ✕ | | | | | ✕ | | | NR | 20 | Low |
---|
Zou, 2018b (38) | | | | | ✕ | | | | ✕ | ✕ | | | NR | 16 | Low |
---|
People with major clinical depression |
---|
Ashdown-Franks, 2019a (2) | | | | | | ✕ | ✕ | ✕ | ✕ | | ✕ | | Jan 2018 | 27 | Moderate |
---|
Krogh, 2017 (20) | | | | | | ✕ | | | ✕ | | | ✕ | Jun 2017 | 35 | Moderate |
---|
Stubbs, 2018a (31) | | | | | | ✕ | ✕ | | ✕ | ✕ | ✕ | ✕ | Jan 2018 | 20 | Moderate |
---|
People with schizophrenia |
---|
Ashdown-Franks, 2019a (2) | | | | | | ✕ | ✕ | ✕ | ✕ | | ✕ | | Jan 2018 | 27 | Moderate |
---|
Firth, 2016 (13) | | | | | | | ✕ | | | | ✕ | | Apr 2016 | 10 | Low |
---|
Stubbs, 2018a (31) | | | | | | ✕ | ✕ | | ✕ | ✕ | ✕ | ✕ | Jan 2018 | 20 | Critically Low |
---|
People with attention deficit hyperactivity disorder |
---|
Ashdown-Franks, 2019a (2) | | | | | | ✕ | ✕ | ✕ | ✕ | | ✕ | | Jan 2018 | 27 | Moderate |
---|
Christiansen, 2019c (7) | | | | | | | | ✕ | | | ✕ | | NR | 18 | N/A |
---|
Grassmann, 2017 (16) | | | | | | | | ✕ | | | ✕ | | NR 2013 | 3 | Critically Low |
---|
Suarez-Manzano, 2018 (33) | | | | | | | | ✕ | | | ✕ | | Jan 2017 | 16 | Critically Low |
---|
Abbreviations: ADHD = attention deficit hyperactivity disorder; ID = intellectual disorder; MCD = major clinical depression; MS = multiple sclerosis; NR = month and/or year not reported; QOL = quality of life; SCI = spinal cord injury
- a
- b
Review excluded given scope
- c
Table F1.2Credibility Ratings (AMSTAR 2)
View in own window
Author, Year | PICO1 | Apriori Methods2 | Study Design Selection3 | Lit Search Strategy4 | Study Selection5 | Data Extraction6 | Excluded Studies7 | Included Studies8 | RoB Assessment9 | Funding Sources10 | Statistical Methods11 | Impact of RoB12 | RoB Results13 | Heterogeneity14 | Publication Bias15 | COI16 | Overall Rating17 |
---|
Alphonsus, 2019 | Y | N | N | PY | Y | N | PY | N | PY | N | Y | Y | Y | Y | Y | N | Low |
Ashdown-Franks, 2019 | Y | N | N | PY | Y | Y | PY | Y | Y | N | N/A | N/A | Y | Y | N/A | Y | Moderate |
Bonini-Rocha, 2018 | Y | N | N | PY | Y | N | PY | PY | Y | N | Y | N | Y | Y | Y | Y | Moderate |
Boyne, 2017 | Y | N | N | PY | N | N | PY | PY | PY | N | Y | N | N | Y | Y | N | Low |
Campbell, 2018 | Y | N | N | PY | N | N | PY | PY | PY | N | N/A | N/A | N | Y | N/A | Y | Low |
Charron, 2018 | Y | N | N | PY | N | N | PY | PY | N | N | N/A | N/A | N | N | N/A | Y | Critically Low |
Cugusi, 2017a | Y | N | N | PY | Y | Y | Y | PY | PY | N | N/A | N/A | N | Y | N/A | Y | Low |
Cugusi, 2017b | N | N | N | PY | Y | Y | Y | Y | Y | N | Y | N | N | Y | Y | Y | Moderate |
Ćwiękała-Lewis, 2017 | N | N | N | PY | N | N | PY | PY | N | N | N/A | N/A | N | N | N/A | Y | Critically Low |
Dos Santos Delabary, 2017 | Y | N | N | PY | Y | Y | PY | PY | Y | N | Y | N | N | Y | Y | Y | Low |
Eitivipart, 201918 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Critically Low |
Firth, 2016 | Y | N | N | PY | Y | N | PY | PY | Y | N | Y | Y | Y | Y | Y | Y | Low |
Gaspar, 2019 | N | N | N | PY | Y | Y | N | N | N | N | N/A | N/A | N | Y | N/A | N | Critically Low |
Ge, 2017 | Y | N | N | PY | Y | Y | PY | PY | Y | N | Y | N | Y | Y | Y | N | Moderate |
Grassmann, 2017 | Y | N | N | PY | N | N | N | PY | N | N | N/A | N/A | N | N | N/A | Y | Critically Low |
Ilunga Tshiswaka, 2018 | N | N | N | PY | Y | N | N | N | N | N | N/A | N/A | N | N | N/A | Y | Critically Low |
Kalyani, 2019 | Y | PY | N | PY | Y | Y | PY | PY | Y | N | N | N | Y | N | N | N | Critically Low |
Krogh, 2017 | Y | PY | N | PY | Y | Y | N | Y | Y | Y | Y | Y | Y | Y | Y | Y | Moderate |
Li, 2018 | Y | N | N | PY | Y | Y | PY | PY | Y | N | Y | N | Y | Y | N | Y | Low |
Maïano, 2018 | Y | N | N | PY | Y | Y | N | Y | PY | N | Y | Y | Y | Y | Y | Y | Low |
Maïano, 2019 | Y | N | N | PY | Y | Y | PY | Y | Y | N | N/A | N/A | Y | N | N/A | Y | Moderate |
Manca, 2018 | Y | N | N | PY | Y | Y | Y | PY | Y | N | Y | N | Y | Y | Y | Y | Moderate |
Melo, 2019 | Y | N | N | PY | Y | Y | PY | PY | N | N | N/A | N/A | N | N | N/A | N | Critically Low |
Miranda, 2018 | N | N | N | PY | N | Y | Y | Y | PY | N | N/A | N/A | Y | Y | N/A | Y | Low |
Morrison, 2017 | N | N | N | PY | N | N | N | Y | PY | N | N/A | N/A | Y | N | N/A | Y | Critically Low |
Patterson, 2018 | Y | N | N | PY | Y | Y | PY | PY | Y | N | N/A | N/A | Y | Y | N/A | Y | Moderate |
Pogrebnoy, 2019 | Y | N | Y | PY | Y | N | PY | PY | PY | N | Y | N | N | Y | N | N | Low |
Schröder, 2018 | Y | N | N | PY | Y | Y | N | PY | Y | N | N/A | N/A | Y | Y | N/A | Y | Low |
Stubbs, 2018 | Y | N | Y | PY | Y | Y | PY | PY | Y | N | N/A | N/A | Y | Y | N/A | Y | Moderate |
Stuckenschneider, 2019 | Y | N | N | PY | N | Y | PY | Y | PY | N | N/A | N/A | Y | Y | N/A | Y | Moderate |
Suarez-Manzano, 2018 | N | N | N | PY | Y | N | N | PY | N | N | N/A | N/A | N | N | N/A | Y | Critically Low |
Veneri, 2018 | N | N | N | PY | Y | N | N | PY | N | N | N | N | N | N | N | Y | Critically Low |
Wiener, 2019 | Y | N | N | PY | Y | N | N | PY | PY | N | N/A | N/A | N | Y | N/A | Y | Low |
Wu, 2018 | Y | N | N | PY | Y | Y | N | PY | N | N | N | N | Y | Y | N | N | Critically Low |
Zou, 2018a | Y | N | N | PY | Y | Y | PY | PY | PY | N | Y | Y | Y | Y | Y | N | Low |
Zou, 2018b | Y | N | N | PY | Y | Y | PY | PY | PY | N | N | N | Y | Y | N | Y | Low |
Abbreviations: COI = conflict of interest; N = no; N/A = not applicable; PICO = population, intervention, comparator, outcome; PY = partial yes; RoB = risk of bias; Y = yes
- 1
Did the research questions and inclusion criteria for the review include the components of PICO?
- 2
Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review and did the report justify any significant deviations from the protocol?
- 3
Did the review authors explain their selection of the study designs for inclusion in the review?
- 4
Did the review authors use a comprehensive literature search strategy?
- 5
Did the review authors perform study selection in duplicate?
- 6
Did the review authors perform data extraction in duplicate?
- 7
Did the review authors provide a list of excluded studies and justify the exclusions?
- 8
Did the review authors describe the included studies in adequate detail?
- 9
Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review?
- 10
Did the review authors report on the sources of funding for the studies included in the review?
- 11
If meta-analysis was performed did the review authors use appropriate methods for statistical combination of results?
- 12
If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis?
- 13
Did the review authors account for RoB in individual studies when interpreting/ discussing the results of the review?
- 14
Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review?
- 15
If they performed quantitative synthesis did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review?
- 16
Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review?
- 17
Shea et al. 2017. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
- 18
Eitivipart, 2019 is a review-of-reviews. All included reviews were rated as critically low by review authors and was therefore rated as critically low overall.
F.1. Physical Activity in children, adolescents and adults living with disability
Table F.1.a. People with multiple sclerosis, relationship between physical activity and health-related outcomes (PDF, 109K)
Questions: What is the association between physical activity and health-related outcomes?
Population: People with multiple sclerosis
Exposure: Greater volume, duration, frequency, or intensity of physical activity
Comparison: No physical activity or lesser volume, duration, frequency, or intensity of physical activity
Outcome: Risk of co-morbid conditions (including disease progression and symptoms of disease), physical function, cognitive function, health-related QOL
Table F.1.b. People with spinal cord injury, relationship between physical activity and health-related outcomes (PDF, 69K)
Questions: What is the association between physical activity and health-related outcomes?
Population: People with spinal cord injury
Exposure: Greater volume, duration, frequency, or intensity of physical activity
Comparison: No physical activity or lesser volume, duration, frequency, or intensity of physical activity
Outcome: Risk of co-morbid conditions (including disease progression and symptoms of disease), physical function, health-related QOL
Table F.1.c. People with intellectual disabilities, relationship between physical activity and health-related outcomes (PDF, 83K)
Questions: What is the association between physical activity and health-related outcomes?
Population: People with intellectual disabilities
Exposure: Greater volume, duration, frequency, or intensity of physical activity
Comparison: No physical activity or lesser volume, duration, frequency, or intensity of physical activity
Outcome: Risk of co-morbid conditions (including disease progression and symptoms of disease), physical function, health-related QOL
Table F.1.d. People with Parkinson’s disease, relationship between physical activity and health-related outcomes (PDF, 106K)
Questions: What is the association between physical activity and health-related outcomes?
Population: People with Parkinson’s disease
Exposure: Greater volume, duration, frequency, or intensity of physical activity
Comparison: No physical activity or lesser volume, duration, frequency, or intensity of physical activity
Outcome: Physical function, cognitive function
Table F.1.e. People with history of stroke, relationship between physical activity and health-related outcomes (PDF, 98K)
Questions: What is the association between physical activity and health-related outcomes?
Population: People with history of stroke
Exposure: Greater volume, duration, frequency, or intensity of physical activity
Comparison: No physical activity or lesser volume, duration, frequency, or intensity of physical activity
Outcome: Physical function, cognitive function
Table F.1.f. People with major clinical depression, relationship between physical activity and health-related outcomes (PDF, 77K)
Questions: What is the association between physical activity and health-related outcomes?
Population: People with major clinical depression
Exposure: Greater volume, duration, frequency, or intensity of physical activity
Comparison: No physical activity or lesser volume, duration, frequency, or intensity of physical activity
Outcome: Health-related QOL
Table F.1.g. People with schizophrenia, relationship between physical activity and health-related outcomes (PDF, 77K)
Questions: What is the association between physical activity and health-related outcomes?
Population: People with schizophrenia
Exposure: Greater volume, duration, frequency, or intensity of physical activity
Comparison: No physical activity or lesser volume, duration, frequency, or intensity of physical activity
Outcome: Cognitive function, health-related QOL
Table F.1.h. People with attention deficit hyperactivity disorder (ADHD), relationship between physical activity and health-related outcomes (PDF, 75K)
Questions: What is the association between physical activity and health-related outcomes?
Population: People with attention deficit hyperactivity disorder (ADHD)
Exposure: Greater volume, duration, frequency, or intensity of physical activity
Comparison: No physical activity or lesser volume, duration, frequency, or intensity of physical activity
Outcome: Cognitive function